{
    "Trade/Device Name(s)": [
        "Stat Profile Prime ES Comp Plus Analyzer System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K191365",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110648"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ",
        "JJE"
    ],
    "Summary Letter Date": "July 19, 2019",
    "Summary Letter Received Date": "May 22, 2019",
    "Submission Date": "May 20, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1665",
        "21 CFR 862.1600",
        "21 CFR 862.1170",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Sodium test system",
        "Potassium test system",
        "Chloride test system",
        "Analyzer, chemistry (photometric, discrete), for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Heparinized venous whole blood",
        "Plasma",
        "Serum"
    ],
    "Specimen Container(s)": [
        "Syringes",
        "Open tubes",
        "Small cups"
    ],
    "Instrument(s)/Platform(s)": [
        "Stat Profile Prime ES Comp Plus Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Ion selective electrode"
    ],
    "Methodologies": [
        "Quantitative analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Stat Profile Prime ES Comp Plus Analyzer System for quantitative measurement of sodium, potassium, and chloride using ion selective electrode technology in clinical laboratory settings",
    "Indications for Use Summary": "For in vitro diagnostic use by healthcare professionals in clinical laboratory settings for quantitative determination of sodium, potassium, and chloride in heparinized venous whole blood, plasma, and serum",
    "fda_folder": "Clinical Chemistry"
}